Company
Establishment Labs
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
0
510(k), De Novo and PMA
Device trials
6
As lead sponsor, any status
Adverse event reports
1,787
Received Nov 1, 2025 to Nov 20, 2026
Recall records
0
One per recalled product
Establishment Labs is on our public-company list (ticker ESTA). Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Establishment Labs, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Establishment Labs.
Latest FDA decisions
No 510(k), De Novo or PMA decisions under this name since 2015.
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT06274736 · 133 participants · Start Apr 10, 2023 · Primary completion Dec 10, 2023
Device: Motiva Sizer · For: Breast Implant; Complications; Breast Implantation; Methods, Safety and Performance; Mammaplasty and 2 more
Sites: Coyol, Costa Rica
- Motiva Flora® Aesthetic Breast Recon® Clinical StudyPivotal-lookingRecruiting
NCT06146231 · 66 participants (planned) · Start Aug 18, 2023 · Primary completion Apr 2026
Device: Motiva Flora® Tissue Expander · For: Mammaplasty; Breast Cancer; Poland Syndrome
Sites: Ghent, Belgium; Bogotá, Colombia; San José, Costa Rica · 4 sites in all
NCT07135011 · 120 participants (planned) · Start Apr 12, 2023 · Primary completion Apr 2026
Device: Primary gluteal enhancement · For: Device Safety
Sites: Alajuela, Costa Rica
3 more trials with a free account
Reports received
1,787
Received Nov 1, 2025 to Nov 20, 2026. Includes 4 of another or unstated type.
Malfunction reports
47
2.6% of reports
Injury reports
1,736
97% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 1 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 3 | 3 | 0 | 0 |
| Jul 24 | 2 | 1 | 0 | 0 |
| Aug 24 | 0 | 1 | 0 | 0 |
| Sep 24 | 1 | 1 | 0 | 0 |
| Oct 24 | 1 | 35 | 0 | 0 |
| Nov 24 | 2 | 47 | 0 | 0 |
| Dec 24 | 6 | 35 | 0 | 0 |
| Jan 25 | 2 | 39 | 0 | 0 |
| Feb 25 | 13 | 73 | 0 | 0 |
| Mar 25 | 10 | 112 | 0 | 0 |
| Apr 25 | 9 | 85 | 0 | 0 |
| May 25 | 11 | 121 | 0 | 0 |
| Jun 25 | 9 | 109 | 0 | 0 |
| Jul 25 | 6 | 84 | 0 | 0 |
| Aug 25 | 8 | 100 | 0 | 0 |
| Sep 25 | 20 | 112 | 0 | 0 |
| Oct 25 | 11 | 164 | 0 | 0 |
| Nov 25 | 4 | 131 | 0 | 0 |
| Dec 25 | 12 | 170 | 0 | 0 |
| Jan 26 | 4 | 115 | 0 | 0 |
| Feb 26 | 0 | 165 | 0 | 0 |
| Mar 26 | 5 | 160 | 0 | 0 |
| Apr 26 | 4 | 114 | 0 | 0 |
| May 26 | 4 | 155 | 0 | 0 |
| Jun 26 | 8 | 118 | 0 | 0 |
| Jul 26 | 1 | 142 | 0 | 0 |
| Aug 26 | 1 | 130 | 0 | 0 |
| Sep 26 | 3 | 179 | 0 | 3 |
| Oct 26 | 1 | 157 | 0 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- MOTIVA IMPLANTS1,762
5 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.